Fecal calprotectin, intestinal ultrasound, and their combination for the diagnosis of Crohn's disease

被引:0
|
作者
Fumery, M. [1 ]
Dubian, S. [1 ]
Brazier, F. [1 ]
Buisson, A. [2 ]
Meynier, J. [3 ]
Yzet, C. [1 ]
机构
[1] Amiens Univ Hosp, Gastroenterol, Amiens 1, France
[2] Clermont Ferrand Univ Hosp, Gastroenterol, Clermont Ferrand, France
[3] Amiens Univ Hosp, Direct Rech Clin, Amiens, France
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P275
引用
收藏
页码:I635 / I635
页数:1
相关论文
共 50 条
  • [31] Diagnosis and differentiation of intestinal tuberculosis and Crohn's disease by use of faecal and serum calprotectin.
    Larsson, G.
    Shenoy, K.
    Roseth, A.
    Bjune, G.
    Moum, B.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S35 - S35
  • [32] Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn's Disease in Clinical Remission
    Raftery, Tara
    Merrick, Megan
    Healy, Martin
    Mahmud, Nasir
    O'Morain, Colm
    Smith, Sinead
    McNamara, Deirdre
    O'Sullivan, Maria
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (08) : 2427 - 2435
  • [33] INTESTINAL PERMEABILITY, FECAL CALPROTECTIN AND CARD 15 MUTATIONS IN FIRST DEGREE RELATIVES OF CROHN'S DISEASE PATIENTS
    Oliva, L.
    D'Inca, R.
    Latiano, A.
    Lamboglia, F.
    Vettorato, M. G.
    Slongo, T.
    Annese, V.
    Sturniolo, G. C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S131 - S132
  • [34] Vitamin D Status Is Associated with Intestinal Inflammation as Measured by Fecal Calprotectin in Crohn’s Disease in Clinical Remission
    Tara Raftery
    Megan Merrick
    Martin Healy
    Nasir Mahmud
    Colm O’Morain
    Sinead Smith
    Deirdre McNamara
    Maria O’Sullivan
    Digestive Diseases and Sciences, 2015, 60 : 2427 - 2435
  • [35] Intestinal permeability, fecal calprotectin and CARD 15 mutations in first degree relatives of Crohn's Disease patients
    D'Inca, Renata
    Oliva, Lydia
    Latiano, Anna
    Lamboglia, Francesca
    Vettorato, Maria G.
    Slongo, Tiziana
    Annese, Vito
    Sturniolo, Giacomo C.
    GASTROENTEROLOGY, 2008, 134 (04) : A497 - A498
  • [36] Intestinal Ultrasonography as an Alternative to Fecal Calprotectin to Monitor Patients with Crohn's Disease: Experience from a Novice Sonographer
    Mathieu, Kelly
    Junda, Jeremy
    Minet-Quinard, Regine
    Coban, Dilek
    Dodel, Marie
    Pereira, Bruno
    Buisson, Anthony
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (09) : 3402 - 3412
  • [37] Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease
    Inokuchi, Toshihiro
    Kato, Jun
    Hiraoka, Sakiko
    Takashima, Shiho
    Nakarai, Asuka
    Takei, Daisuke
    Sugihara, Yuusaku
    Takahara, Masahiro
    Kawano, Seiji
    Harada, Keita
    Okada, Hiroyuki
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (05) : 1078 - 1085
  • [38] Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease
    Inokuchi, Toshihiro
    Kato, Jun
    Hiraoka, Sakiko
    Takashima, Shiho
    Takei, Daisuke
    Nakarai, Asuka
    Sugihara, Yuusaku
    Kawano, Seiji
    Harada, Keita
    Okada, Hiroyuki
    Yamamoto, Kazuhide
    GASTROENTEROLOGY, 2015, 148 (04) : S451 - S451
  • [39] Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease
    Inokuchi, Toshihiro
    Kato, Jun
    Hiraoka, Sakiko
    Takashima, Shiho
    Takei, Daisuke
    Nakarai, Asuka
    Sugihara, Yuusaku
    Takahara, Masahiro
    Harada, Keita
    Kawano, Seiji
    Okada, Hiroyuki
    GASTROENTEROLOGY, 2016, 150 (04) : S991 - S991
  • [40] Fecal calprotectin is an effective marker of disease activity in patients with ileal Crohn's disease
    Picardo, S.
    So, K.
    Venugopal, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 140 - 141